What is Recursion Pharmaceuticals, Inc.'s gross margin?

Recursion Pharmaceuticals, Inc. (RXRX) reported gross margin of 7.2% in Q1 2026.

What is the long-term trend for Recursion Pharmaceuticals, Inc.'s gross margin?

Over 3 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s gross margin has grown at a -63.2% compound annual growth rate (CAGR), from 100% to 5%.

What does gross margin mean?

Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.

Recursion Pharmaceuticals, Inc. RXRX Gross margin

Gross margin at other companies

BridgeBio PharmaBBIO

95.1%-0.2pp

BioCryst PharmaceuticalsBCRX

97.8%+0.8pp

Nektar TherapeuticsNKTR

100%+31.2pp

Lantheus HoldingsLNTH

60.5%-3.6pp

Other financials

Income statement

See full

Revenue$6.5M-56.1%

Gross profit-$6.0M+15.0%

Operating income-$128.5M+32.8%

Net income-$117.5M+42.0%

EPS (diluted)-$0.22+56.0%

Balance sheet

See full

Cash & equivalents$665.2M+30.6%

Total debt$88.6M-24.6%

Total equity$1.0B+9.7%

Total assets$1.3B+2.6%

Cash flow

See full

Operating cash flow-$81.1M+38.5%

CapEx$258.0K-85.9%

Free cash flow-$81.4M+39.2%

Valuation

See full

Market cap$1.68B-23.7%

Enterprise value$1.1B-39.8%

P/S25.3×-11.5×

Profitability

See full

Operating margin-881.3%-66.8pp

Net margin-842.9%-92.4pp

FCF margin-490.7%-102pp

Returns & leverage

See full

Return on equity-57.2%-14.4pp

Debt / equity0.1×0.0×

Current ratio5.5×+1.4×

Where this comes from

Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.

gross profit/total revenue=7.2%

Based on trailing twelve months.

The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Recursion Pharmaceuticals, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Recursion Pharmaceuticals, Inc.'s gross margin?: Recursion Pharmaceuticals, Inc. (RXRX) reported gross margin of 7.2% in Q1 2026.
What is the long-term trend for Recursion Pharmaceuticals, Inc.'s gross margin?: Over 3 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s gross margin has grown at a -63.2% compound annual growth rate (CAGR), from 100% to 5%.
What does gross margin mean?: Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.